These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 25890726)
1. Multifunctional effects of honokiol as an anti-inflammatory and anti-cancer drug in human oral squamous cancer cells and xenograft. Cho JH; Jeon YJ; Park SM; Shin JC; Lee TH; Jung S; Park H; Ryu J; Chen H; Dong Z; Shim JH; Chae JI Biomaterials; 2015; 53():274-84. PubMed ID: 25890726 [TBL] [Abstract][Full Text] [Related]
2. Role of transcription factor Sp1 in the 4-O-methylhonokiol-mediated apoptotic effect on oral squamous cancer cells and xenograft. Cho JH; Lee RH; Jeon YJ; Shin JC; Park SM; Choi NJ; Seo KS; Yoon G; Cho SS; Kim KH; Cho JJ; Cho YS; Kim DH; Hong JT; Lee TH; Park HJ; Jung S; Seo JM; Chen H; Dong Z; Chae JI; Shim JH Int J Biochem Cell Biol; 2015 Jul; 64():287-97. PubMed ID: 25982202 [TBL] [Abstract][Full Text] [Related]
3. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy. Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886 [TBL] [Abstract][Full Text] [Related]
4. Anticancer activity of Honokiol against lymphoid malignant cells via activation of ROS-JNK and attenuation of Nrf2 and NF-κB. Gao DQ; Qian S; Ju T J BUON; 2016; 21(3):673-9. PubMed ID: 27569089 [TBL] [Abstract][Full Text] [Related]
5. Anti-proliferative effect of honokiol in oral squamous cancer through the regulation of specificity protein 1. Kim DW; Ko SM; Jeon YJ; Noh YW; Choi NJ; Cho SD; Moon HS; Cho YS; Shin JC; Park SM; Seo KS; Choi JY; Chae JI; Shim JH Int J Oncol; 2013 Oct; 43(4):1103-10. PubMed ID: 23877711 [TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo. Yasuda A; Kondo S; Nagumo T; Tsukamoto H; Mukudai Y; Umezawa K; Shintani S Oral Oncol; 2011 May; 47(5):334-9. PubMed ID: 21459660 [TBL] [Abstract][Full Text] [Related]
7. Esculetin (6,7-dihydroxycoumarin): a potential cancer chemopreventive agent through suppression of Sp1 in oral squamous cancer cells. Cho JH; Shin JC; Cho JJ; Choi YH; Shim JH; Chae JI Int J Oncol; 2015 Jan; 46(1):265-71. PubMed ID: 25310400 [TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells. Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776 [TBL] [Abstract][Full Text] [Related]
9. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice. Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373 [TBL] [Abstract][Full Text] [Related]
10. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593 [TBL] [Abstract][Full Text] [Related]
11. Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma. Zhang Y; Yuan Y; Wu H; Xie Z; Wu Y; Song X; Wang J; Shu W; Xu J; Liu B; Wan L; Yan Y; Ding X; Shi X; Pan Y; Li X; Yang J; Zhao X; Wang L Int J Cancer; 2018 Aug; 143(4):980-991. PubMed ID: 29536537 [TBL] [Abstract][Full Text] [Related]
12. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction. Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679 [TBL] [Abstract][Full Text] [Related]
13. Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo. Zhang X; Su Y; Zhang M; Sun Z Cancer Lett; 2012 May; 318(1):93-8. PubMed ID: 22155346 [TBL] [Abstract][Full Text] [Related]
14. Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes. Chen YJ; Tsai KS; Chan DC; Lan KC; Chen CF; Yang RS; Liu SH J Orthop Res; 2014 Apr; 32(4):573-80. PubMed ID: 24375705 [TBL] [Abstract][Full Text] [Related]
15. Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse. Wen J; Wang X; Pei H; Xie C; Qiu N; Li S; Wang W; Cheng X; Chen L J Pharmacol Sci; 2015 Jul; 128(3):116-24. PubMed ID: 26220468 [TBL] [Abstract][Full Text] [Related]
16. Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress. Chen YJ; Wu CL; Liu JF; Fong YC; Hsu SF; Li TM; Su YC; Liu SH; Tang CH Cancer Lett; 2010 May; 291(1):20-30. PubMed ID: 19880244 [TBL] [Abstract][Full Text] [Related]
17. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling. Chang MT; Lee SP; Fang CY; Hsieh PL; Liao YW; Lu MY; Tsai LL; Yu CC; Liu CM Environ Toxicol; 2018 Nov; 33(11):1105-1112. PubMed ID: 30076764 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma. Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022 [TBL] [Abstract][Full Text] [Related]
19. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies. Yue B; Zhao CR; Xu HM; Li YY; Cheng YN; Ke HN; Yuan Y; Wang RQ; Shi YQ; Lou HX; Qu XJ Biochim Biophys Acta; 2013 Jan; 1830(1):2194-203. PubMed ID: 23085067 [TBL] [Abstract][Full Text] [Related]
20. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer. Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]